enfortumab vedotin Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

Astellas Pharma Global Development, Inc. (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcarcinoma

I am/have/hadexternal beam radiation therapy

I am/have/hadmetastatic urothelial carcinoma

I am/have/hadadjuvant chemotherapy

I am/have/hadsystemic therapy

I am/have/hadtransitional cell carcinoma

I am/have/hadpd-l1

I am/have/hadmeasurable disease

I am/have/hadcancer

added new label for I am/have/had

more

I am looking for

I am looking forenfortumab vedotin

I am looking forcarboplatin

I am looking forgemcitabine

I am looking forcisplatin

I am looking forimmunomodulator

I am looking forpembrolizumab

I am looking forimmunomodulators

I am looking foradjuvant

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Enfortumab Vedotin and Pembrolizumab With or Without Chemotherapy vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

This study is being done to see how well two drugs (enfortumab vedotin and pembrolizumab) work together alone or with platinum chemotherapy to treat patients with urothelial cancer. The study will compare these drugs to other drugs that are usually used to treat this cancer (standard of care).

enfortumab vedotin

gemcitabine

pembrolizumab

measurable disease

systemic therapy

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.